Source Feed: The Globe and Mail
Author: Kelly Grant
Publication Date: October 26, 2025 - 21:08
Health Canada approves drug that slows progression of Alzheimer’s disease
October 26, 2025
Health Canada has for the first time approved a disease-modifying drug for Alzheimer’s disease, a watershed moment that offers hope for patients but does not guarantee that the complex and expensive intravenous therapy will be widely available in this country.
The federal regulator on Friday granted a conditional authorization for lecanemab, an antibody drug that can slow the progression of the disease for some people with mild cognitive impairment or early-stage dementia owing to Alzheimer’s.
This is from a story about the scalping of British settlers and militia by Mi’kmaq warriors in what became known as the “Dartmouth Massacre” on May 13, 1751, from John Wilson’s eyewitness account: “These Indians chain the unfortunate prisoner to a large thick tree, and bind his hands and his feet, then beginning from the middle of the craneum, they cut quite round towards the neck; this being done, they then tear off the skin, leaving the skull bare; an inflammation quickly follows, the patient fevers, and dies in the most exquisite tortures.”
Wilson’s account is not the only record...
November 22, 2025 - 07:00 | Special to National Post | National Post
Alberta radio host Kim Johnston says his worsening symptoms and a months-long wait for a neurosurgery consult show how specialist delays are straining rural health care.
November 22, 2025 - 07:00 | Alessia Simona Maratta | Global News - Canada
In the final installment of the Global News' series Unheard. Unserved, we look how gender and race can intersect to create even deeper gaps in treatment and outcomes for women.
November 22, 2025 - 07:00 | Ella Macdonald | Global News - Canada


Comments
Be the first to comment